Search research articles
Contact Us
Filters
Showing results (31-40 of 73) with videos related to
Page
of 8
Sort By:
Journal of Assisted Reproduction and Genetics
|
November 17, 2014
Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model
J Cohen, A Ziyyat, I Naoura, et al.
Human Reproduction (Oxford, England)
|
May 15, 1999
Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B?
N Lahlou, N Chabbert-Buffet, S Christin-Maitre, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
July 31, 2016
Incidental cervical metastases from thyroid carcinoma during neck dissection
S Périé, F Torti, M Lefevre, et al.
Human Reproduction (Oxford, England)
|
March 23, 2011
Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study
S Christin-Maitre, D Serfaty, N Chabbert-Buffet, et al.
Clinical Endocrinology
|
June 10, 2000
Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation
S Christin-Maitre, F Olivennes, S Dubourdieu, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
January 12, 2021
[Fertility preservation for transwomen]
E Benaloun, N Sermondade, E Moreau, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
December 20, 2018
[Expert centre Cancer du sein et Grossesse (CALG): Concordance between the proposed therapeutics and those finally received]
J De Garnier, A S Boudy, L Selleret, et al.
Frontiers in Global Women'S Health
|
April 24, 2024
Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4)
M D Creinin, A Cagnacci, R Z Spaczyński, et al.
Journal Des Maladies Vasculaires
|
November 18, 2003
Cutaneous microvascular effects of mid-term hormone replacement therapy in healthy postmenopausal women: a prospective placebo controlled trial
N Chabbert-Buffet, P Bonnin, B Lévy, et al.
Anticancer Research
|
July 31, 2012
Predictive factors for breast cancer in patients diagnosed with ductal intraepithelial neoplasia, grade 1B
S Bendifallah, N Chabbert-Buffet, N Maurin, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 73) with videos related to
Sort By:
Page
of 8
Journal of Assisted Reproduction and Genetics
|
November 17, 2014
Effect of induced peritoneal endometriosis on oocyte and embryo quality in a mouse model
J Cohen, A Ziyyat, I Naoura, et al.
Human Reproduction (Oxford, England)
|
May 15, 1999
Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B?
N Lahlou, N Chabbert-Buffet, S Christin-Maitre, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
July 31, 2016
Incidental cervical metastases from thyroid carcinoma during neck dissection
S Périé, F Torti, M Lefevre, et al.
Human Reproduction (Oxford, England)
|
March 23, 2011
Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study
S Christin-Maitre, D Serfaty, N Chabbert-Buffet, et al.
Clinical Endocrinology
|
June 10, 2000
Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation
S Christin-Maitre, F Olivennes, S Dubourdieu, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
January 12, 2021
[Fertility preservation for transwomen]
E Benaloun, N Sermondade, E Moreau, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
December 20, 2018
[Expert centre Cancer du sein et Grossesse (CALG): Concordance between the proposed therapeutics and those finally received]
J De Garnier, A S Boudy, L Selleret, et al.
Frontiers in Global Women'S Health
|
April 24, 2024
Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4)
M D Creinin, A Cagnacci, R Z Spaczyński, et al.
Journal Des Maladies Vasculaires
|
November 18, 2003
Cutaneous microvascular effects of mid-term hormone replacement therapy in healthy postmenopausal women: a prospective placebo controlled trial
N Chabbert-Buffet, P Bonnin, B Lévy, et al.
Anticancer Research
|
July 31, 2012
Predictive factors for breast cancer in patients diagnosed with ductal intraepithelial neoplasia, grade 1B
S Bendifallah, N Chabbert-Buffet, N Maurin, et al.
Page
of 8